New Delhi [India], August 31 (ANI/NewsVoir): To enable clinicians to rapidly test for TB and multidrug resistance as a first-line test, BD Diagnostics, a segment of BD Lifesciences (Becton, Dickinson, and Company), today introduced the BD MAX molecular diagnostic system and availability of the BD MAX™ MDR-TB panel in India.
\
\
